About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Jun 22, 2010...
World-renowned immunologist Prof. Ruth Arnon of the Weizmann Institute has been named the new – and first woman – president of the Israel Academy of Sciences and the Humanities, since 1961 the government's official adviser on science and planning of civilian research.
She replaces Prof. Menahem Ya'ari, who held the position for two three-year terms.
The academy also announced on Monday that Arnon's vice president will be Prof. Binyamin Ze'ev Kedar. Both were elected at a general assembly of 100 academy members, and they will take office around Rosh Hashana. The social sciences and humanities are represented in the academy along with the exact sciences.
https://www.weizmann-usa.org/news-media/feature-stories/p53-and-personalized-medicine/
Jan 06, 2010...
As a postdoctoral researcher at the Massachusetts Institute of Technology (MIT) 30 years ago, Prof. Varda Rotter was among the first scientists to study a little-known gene called p53. "We didn't know then that it was going to turn out to be so important for cancer research," she says.
It was during those early days of her research in the laboratory of microbiologist and Nobel laureate David Baltimore that she realized, she says, "that science is one of the most exciting things one can do—you can really pursue your dreams."
Jul 05, 2015...
Prof. Ruth Arnon presenting report to Science, Technology and Space Minister Danny Danon. (photo credit:JUDY SIEGEL-ITZKOVICH)
Although women constitute the majority of students at all levels in institutions of higher learning, they are seriously under-represented among senior academic staff in universities and state-budgeted colleges, depriving the country of female brainpower, according to a Sunday report from the Israel Academy of Sciences and Humanities and the Council for Higher Education.
Aug 05, 2014...
Source: Shutterstock.com
REHOVOT, ISRAEL—August 5, 2014—Laboratory mice are one of the most common animal models used in biological and medical research. Thousands of laboratory mouse strains are produced by artificial selection – the process by which humans breed animals over dozens of generations for particular traits. This has led to the domestication of mice: strengthening specific qualities that make them well-adapted for research under laboratory conditions, such as rapid reproduction, while eliminating characteristics that are not conducive to research, for example, aggression, the desire and ability to escape from danger, and anxiety caused by environmental disturbances.
Mar 03, 2016...
At the inaugural Women for Science virtual conference, guests watched a live video broadcast by Prof. Idit Shachar. Credit: Melanie Einzig
On Tuesday, February 23rd, 2016, the American Committee for the Weizmann Institute of Science hosted the first Women for Science (W4S) virtual conference. Spanning four time zones and attracting over 100 participants, the conference linked attendees to the Weizmann Institute campus from seven video conferencing sites across the U.S. – New York City, San Francisco, Chicago, Detroit, Los Angeles, North Miami, FL, and Coral Gables, FL. Live from Rehovot, Prof. Idit Shachar, Head of the Department of Immunology and incumbent of the Dr. Morton and Anne Kleiman Professorial Chair, discussed the role of immune cells in health and disease.
Oct 01, 2017...
October is National Breast Cancer Awareness Month, and people everywhere are running, walking, and even shopping in support – and, at Israel’s Weizmann Institute of Science, investigating, researching, and pursuing creative new ways to attack this still-insidious, too-common disease.
The Weizmann Institute has a history of successfully fighting breast cancer; for example, the Susan G. Komen Breast Cancer Foundation supported early Weizmann research that helped develop Herceptin® (trastuzumab), one of the first – and most widely used – breast cancer drugs on the market. Today, thanks to the Institute’s new Moross Integrated Cancer Center, which will enable highly specific focus on individual cancers, breast cancer research will become ever more advanced and personalized.Here are just a few of our current investigations into breast cancer:
https://www.weizmann-usa.org/news-media/feature-stories/prof-michal-schwartz-will-change-your-mind/
Sep 22, 2015... September 21st is World Alzheimer’s Day – and, not coincidentally, the release date for Prof. Michal Schwartz’s new book. Published by Yale University Press, Neuroimmunity: A New Science That Will Revolutionize How We Keep Our Bodies Healthy and Young not only presents her game-changing work on the immune system’s connection to the brain, but brings to life her extraordinary journey as a woman in science.
https://www.weizmann-usa.org/news-media/in-the-news/making-science-and-family-fit/
Feb 05, 2010... Israeli structural biologist Michal Sharon has made some bold decisions in her young scientific career. After productively using nuclear magnetic resonance (NMR) spectroscopy to study protein structure during a Ph.D., she switched to structural mass spectrometry for her postdoc in the United Kingdom. Upon taking a tenure-track position at the Weizmann Institute of Science in Rehovot 3 years ago, she set out to create the first structural mass spectrometry lab in Israel. And when she wrote the proposal that won a European Research Council starting grant, she let her scientific ambition run free, asking herself, “What will I want to investigate ... if money was not a concern?”
Oct 20, 2015... Before breakthroughs in breast cancer research ever appear in the news or on the market, there are cadres of researchers working tirelessly, largely unseen, to develop these improvements. At the Weizmann Institute, these scientists are coming together from across the fields – biologists and mathematicians, geneticists and chemists, plants scientists and physicists – in the interest of defeating breast cancer.
https://www.weizmann-usa.org/news-media/news-releases/new-algorithm-predicts-gestational-diabetes/
Jan 13, 2020... REHOVOT, ISRAEL—January 13, 2020—A new computer algorithm enables prediction, in the early stages of pregnancy or even before pregnancy has occurred, of which women are at a high risk of gestational diabetes. Conducted by researchers at the Weizmann Institute of Science, the study was reported in Nature Medicine. The scientists analyzed data on nearly 600,000 pregnancies available from Israel’s largest health organization, Clalit Health Services. It may be possible, based on these predictions, to prevent gestational diabetes using nutritional and lifestyle changes.
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR
